Scatter plots of photo score by age and blue reaction time. by Richard C. Trevino (22676460)

Subjects:

Mean hemoglobin levels of Roxadustat and ESAs groups over time. by Jie Liu (15128)

Subjects:

Effects of finerenone on the UACR in all patients. by Jia Song (495396)

Subjects:

Changes in blood pressure, HbA1c, blood lipids and liver function-related indicator values from 3 months to 6 months of treatment in all patients. by Jia Song (495396)

Subjects:

Comparison of the rates of decline in the UACR and urinary β2-MG levels between the two subgroups. by Jia Song (495396)

Subjects:

Effects of finerenone on the urinary β2-MG levels in all patients. by Jia Song (495396)

Subjects:

Baseline characteristics of the participants. by Jia Song (495396)

Subjects:

Summary map of all contacts with statistically significant SVM classifications. by Alexander P. Rockhill (6053618)

“…<p>The top row presents the proportion of significant SVM clusters. It illustrates what proportions of channels are significant at that time-frequency ranging from 0 to 1. …”

Changes in Burnout, Resilience, and PTS Across Time Using Repeated Measures ANOVA. by Rachel G. Baskin (22127334)

Subjects:

Distribution of time to cardiac surgery following preoperative cardiac arrest (pCA). by Amulya Vadlakonda (15449215)

Subjects:

Irrigation and fertilization timing during the tomato growth stage. by Xiaona Lyu (20871872)

Subjects:

Effects of GJE extract treatment decreased protein expression of MMP-12, α-SMA, IL-13, and TGF-β1 levels. by Natnicha Suttawong (22367172)

Frequency distribution of SOLEC at baseline and follow-ups in WAD grade 2 and WAD grade 3. by Anneli Peolsson (7867601)

Subjects:

The CONSORT flow diagram. by Anneli Peolsson (7867601)

Subjects:

Baseline descriptive characteristics of trial participants (n = 140) with and without dizziness. by Anneli Peolsson (7867601)

Subjects:

Frequency distribution of SOLEC at baseline and follow-ups in the NSEIT and NSE groups. by Anneli Peolsson (7867601)

Subjects:

Outcomes in DHI score, dizziness and unsteadiness at baseline and at three- and 15-month follow-ups for each WAD group, and within-group effects. by Anneli Peolsson (7867601)

Subjects:

Baseline descriptive characteristics of trial participants with dizziness, by treatment group. by Anneli Peolsson (7867601)

Subjects:

Outcomes in DHI score, dizziness and unsteadiness at baseline and at three- and 15-month follow-ups for each intervention group, and within-group effects. by Anneli Peolsson (7867601)

Subjects:

Representative immunohistochemistry images of PCNA expression in renal tissues among CG, NG, NVG, and NVRG (×400). by Jian-feng Li (8667645)

Subjects: